|
1
|
Yao Y and Dai W: Genomic instability and
cancer. J Carcinog Mutagen. 5:10001652014.PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mc Gee MM: Targeting the mitotic
catastrophe signaling pathway in cancer. Mediators Inflamm.
2015:1462822015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vitale I, Galluzzi L, Castedo M and
Kroemer G: Mitotic catastrophe: A mechanism for avoiding genomic
instability. Nat Rev Mol Cell Biol. 12:385–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kimura M, Yoshioka T, Saio M, Banno Y,
Nagaoka H and Okano Y: Mitotic catastrophe and cell death induced
by depletion of centrosomal proteins. Cell Death Dis. 4:e6032013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vakifahmetoglu H, Olsson M and Zhivotovsky
B: Death through a tragedy: Mitotic catastrophe. Cell Death Differ.
15:1153–1162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castedo M, Perfettini JL, Roumier T,
Andreau K, Medema R and Kroemer G: Cell death by mitotic
catastrophe: A molecular definition. Oncogene. 23:2825–2837. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denisenko TV, Sorokina IV, Gogvadze V and
Zhivotovsky B: Mitotic catastrophe and cancer drug resistance: A
link that must to be broken. Drug Resist Updat. 24:1–12. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi M, Yao G, Fan S, Cheng W, Tashiro S,
Onodera S and Ikejima T: Pseudolaric acid B induces mitotic
catastrophe followed by apoptotic cell death in murine fibrosarcoma
L929 cells. Eur J Pharmacol. 683:16–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu YC, Yen WY, Ho HY, Su TL and Yih LH:
Glyfoline induces mitotic catastrophe and apoptosis in cancer
cells. Int J Cancer. 126:1017–1028. 2010.PubMed/NCBI
|
|
11
|
Cragg GM and Pezzuto JM: Natural products
as a vital source for the discovery of cancer chemotherapeutic and
chemopreventive agents. Med Princ Pract. 25 (Suppl 2):S41–S59.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bais S, Gill NS, Rana N and Shandil S: A
phytopharmacological review on a medicinal plant: Juniperus
communis. Int Sch Res Notices. 2014:6347232014.PubMed/NCBI
|
|
13
|
Tavares WR and Seca AML: The current
status of the pharmaceutical potential of Juniperus L.
Metabolites. Medicines (Basel). 5:812018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raasmaja A, Stenius U and Ghalali A: The
Water Extract of Juniperus communis L. Induces cell death
and sensitizes cancer cells to cytostatic drugs through p53 and
PI3K/Akt Pathways. Int J Mol Sci. 20:20542019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee CC, Hsiao CY, Lee SC, Huang XF, Chang
KF, Lee MS, Hsieh MC and Tsai NM: Suppression of oral cancer by
induction of cell cycle arrest and apoptosis using Juniperus
communis extract. Biosci Rep. 40:BSR202020832020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Al Groshi A, Jasim HA, Evans AR, Ismail
FMD, Dempster NM, Nahar L and Sarker SD: Growth inhibitory activity
of biflavonoids and diterpenoids from the leaves of the Libyan
Juniperus phoenicea against human cancer cells. Phytother
Res. 33:2075–2082. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang IH, Jung W, Kim LH, Shin JA, Cho NP,
Hong SD, Hong KO and Cho SD: Nitidine chloride represses Mcl-1
protein via lysosomal degradation in oral squamous cell carcinoma.
J Oral Pathol Med. 47:823–829. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tajmirriahi N, Razavi SM, Shirani S,
Homayooni S and Gasemzadeh G: Evaluation of metastasis and 5-year
survival in oral squamous cell carcinoma patients in Isfahan
(2001–2015). Dent Res J (Isfahan). 16:117–121. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Omura K: Current status of oral cancer
treatment strategies: Surgical treatments for oral squamous cell
carcinoma. Int J Clin Oncol. 19:423–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szturz P and Vermorken JB: Management of
recurrent and metastatic oral cavity cancer: Raising the bar a step
higher. Oral Oncol. 101:1044922020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Crooker K, Aliani R, Ananth M, Arnold L,
Anant S and Thomas SM: A review of promising natural
chemopreventive agents for head and neck cancer. Cancer Prev Res
(Phila). 11:441–450. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu HJ, Shin JA, Yang IH, Won DH, Ahn CH,
Kwon HJ, Lee JS, Cho NP, Kim EC, Yoon HJ, et al: Apoptosis induced
by caffeic acid phenethyl ester in human oral cancer cell lines:
Involvement of Puma and Bax activation. Arch Oral Biol. 84:94–99.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang IH, Shin JA, Lee KE, Kim J, Cho NP
and Cho SD: Oridonin induces apoptosis in human oral cancer cells
via phosphorylation of histone H2AX. Eur J Oral Sci. 125:438–443.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morse DL, Gray H, Payne CM and Gillies RJ:
Docetaxel induces cell death through mitotic catastrophe in human
breast cancer cells. Mol Cancer Ther. 4:1495–1504. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin YW, Raj EN, Liao WS, Lin J, Liu KK,
Chen TH, Cheng HC, Wang CC, Li LY, Chen C and Chao JI: Co-delivery
of paclitaxel and cetuximab by nanodiamond enhances mitotic
catastrophe and tumor inhibition. Sci Rep. 7:98142017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan S, Guan X, Grun C, Zhou Z, Schepers U
and Nick P: Gallic acid induces mitotic catastrophe and inhibits
centrosomal clustering in HeLa cells. Toxicol In Vitro. 30:506–513.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Levrier C, Rockstroh A, Gabrielli B,
Kavallaris M, Lehman M, Davis RA, Sadowski MC and Nelson CC:
Discovery of thalicthuberine as a novel antimitotic agent from
nature that disrupts microtubule dynamics and induces apoptosis in
prostate cancer cells. Cell Cycle. 17:652–668. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qu Z, Zou X, Zhang X, Sheng J, Wang Y,
Wang J, Wang C and Ji Y: Chelidonine induces mitotic slippage and
apoptotic-like death in SGC-7901 human gastric carcinoma cells. Mol
Med Rep. 13:1336–1344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kundu S, Kim TH, Yoon JH, Shin HS, Lee J,
Jung JH and Kim HS: Viriditoxin regulates apoptosis and autophagy
via mitotic catastrophe and microtubule formation in human prostate
cancer cells. Int J Oncol. 45:2331–2340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamaguchi R, Lartigue L and Perkins G:
Targeting Mcl-1 and other Bcl-2 family member proteins in cancer
therapy. Pharmacol Ther. 195:13–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiang W, Yang CY and Bai L: MCL-1
inhibition in cancer treatment. Onco Targets Ther. 11:7301–7314.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wen Q, Zhan Y, Zheng H, Zang H, Luo J,
Zhang Y, Wang W, Feng J, Lu J, Chen L and Fan S: Elevated
expression of mcl-1 inhibits apoptosis and predicts poor prognosis
in patients with surgically resected non-small cell lung cancer.
Diagn Pathol. 14:1082019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hird AW and Tron AE: Recent advances in
the development of Mcl-1 inhibitors for cancer therapy. Pharmacol
Ther. 198:59–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Muller F, Cerella C, Radogna F, Dicato M
and Diederich M: Effects of natural products on Mcl-1 expression
and function. Curr Med Chem. 22:3447–3461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han JM, Hong KO, Yang IH, Ahn CH, Jin B,
Lee W, Jung YC, Kim KA, Shin JA, Cho SD and Hong SD: Oridonin
induces the apoptosis of mucoepidermoid carcinoma cell lines in a
myeloid cell leukemia-1dependent manner. Int J Oncol. 57:377–385.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Keskes H, Belhadj S, Jlail L, El Feki A,
Damak M, Sayadi S and Allouche N: LC-MS-MS and GC-MS analyses of
biologically active extracts and fractions from Tunisian
Juniperus phoenicea leaves. Pharm Biol. 55:88–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pollio A, Zarrelli A, Romanucci V, Di
Mauro A, Barra F, Pinto G, Crescenzi E, Roscetto E and Palumbo G:
Polyphenolic profile and targeted bioactivity of methanolic
extracts from mediterranean ethnomedicinal plants on human cancer
cell lines. Molecules. 21:3952016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wedge DE, Tabanca N, Sampson BJ, Werle C,
Demirci B, Baser KH, Nan P, Duan J and Liu Z: Antifungal and
insecticidal activity of two Juniperus essential oils. Nat Prod
Commun. 4:123–127. 2009.PubMed/NCBI
|
